Raphael Pharmaceutical RAPH
OTC RAPH
$1.40 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Raphael Pharmaceutical (RAPH) Return on Capital Employed [ROCE] (2022 - 2023)

Updated

Raphael Pharmaceutical (RAPH) recorded Return on Capital Employed [ROCE] of -673.02% in Q4 2023.

Analysis

Raphael Pharmaceutical (RAPH) Return on Capital Employed [ROCE] (2022 - 2023) Analysis & Trends

For FY2023, Raphael Pharmaceutical reported Return on Capital Employed [ROCE] of -825.97%, up 1378.01 percentage points from FY2022.

  • Across earlier years, Return on Capital Employed [ROCE] came in at -2203.99% in FY2022 (-128.83 pp) and -2075.16% in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Raphael Pharmaceutical 28.25 Mn 28.18 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -673.02%
Mar 31, 2023 -4,121.21%
Jun 30, 2022 -1,617.27%
Mar 31, 2022 -692.86%
API Access

Raphael Pharmaceutical Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=RAPH&period=max&api_key=YOUR_API_KEY